Allegheny Health Network's 'Alcohol Bridge Clinic' Transforms Treatment of Alcohol-Associated Liver Disease Multidisciplinary clinic shows early success in helping patients achieve sobriety and ...

Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis—a ...

By Danilo Masoni MILAN, Jan 28 (Reuters) - A surge in Inventiva shares, up about 50% in the first few weeks of 2026, highlights investors' appetite for betting on the loss-making French biotech, which ...

Cytotheryx, a growing Rochester biotech firm working on treatments for liver disease, recently received $60 million in ...

A groundbreaking international trial has found that semaglutide, a drug best known for treating diabetes and obesity, can also reverse a dangerous liver disease called MASH in nearly two-thirds of ...

The diabetes and weight loss drug semaglutide may also reverse signs of liver disease. That’s the headline result of a new clinical trial that tested the popular medication in patients with MASH, or ...

A multicenter research effort in China conducted clinical trial testing of oral berberine for six months in diabetes-free ...

Liver cancer remains a significant global health challenge and can develop silently in patients who are unaware they have underlying liver disease. To discuss this unmet need in cancer care, CURE sat ...

A new blood test may help detect liver cancer earlier in people with chronic liver disease, potentially improving access to ...

Liver cancer, primarily hepatocellular carcinoma, originates in the liver, with hepatitis B and C as major risk factors. Diagnosis involves physical exams, blood tests, imaging, and possibly biopsy to ...

Jan 23 (Reuters) - Bausch Health said on Friday its experimental treatment failed to prevent the first clinically visible symptoms of a neurological condition in patients with a type of liver disease, ...

ALL RIGHT, ERIC, THANKS SO MUCH. A GROWING LIVER PROBLEM IS NOW AFFECTING MILLIONS OF PEOPLE. KOAT UNM HEALTH EXPERT DOCTOR ASH SPOKE WITH DARLENE MELENDEZ ABOUT IT. NONALCOHOLIC FATTY LIVER DISEASE ...